论文部分内容阅读
转移因子(Transfer factor TF)具有触发和增强机体的细胞免疫功能,是细胞免疫反应中一种重要介质。自Levin 1970年首先用转移因子治疗一种细胞免疫缺陷病后,近10年来被临床医师所重视。由于在慢性肝炎病人血清中常存在乙型肝炎表面抗原(HBsAg),而HBsAg长期持续存在则可导致自身免疫损害,并且可能由慢性活动性肝炎发展成为肝硬化,因此近年来有人应用淋巴转移因子治疗慢性肝炎及肝硬化,取得初步的效果。1974
Transfer factor TF, which triggers and enhances cellular immunity, is an important mediator of cellular immune responses. Since Levin first used the transfer factor in 1970 to treat one kind of cellular immunodeficiency disease, it has been valued by clinicians for nearly 10 years. Due to the presence of hepatitis B surface antigen (HBsAg) in the serum of patients with chronic hepatitis and long-term persistence of HBsAg can lead to autoimmune damage, and may develop from chronic active hepatitis to cirrhosis, so some people in recent years with lymphatic metastasis factor therapy Chronic hepatitis and cirrhosis, and achieved initial results. 1974